1977
DOI: 10.1038/265081a0
|View full text |Cite
|
Sign up to set email alerts
|

Concanavalin A as a carrier of daunomycin

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
17
0

Year Published

1979
1979
2004
2004

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 65 publications
(17 citation statements)
references
References 2 publications
0
17
0
Order By: Relevance
“…PNA, if bound to a drug, may direct and concentrate the drug on this pathologic subpopulation. The use of daunomycin bound to concanavalin A has been demonstrated in a mouse model system (17). The advantage of PNA over other lectins is that it does not interact significantly with human erythrocytes (5) or with normal peripheral blood lymphocytes.…”
Section: Methodsmentioning
confidence: 99%
“…PNA, if bound to a drug, may direct and concentrate the drug on this pathologic subpopulation. The use of daunomycin bound to concanavalin A has been demonstrated in a mouse model system (17). The advantage of PNA over other lectins is that it does not interact significantly with human erythrocytes (5) or with normal peripheral blood lymphocytes.…”
Section: Methodsmentioning
confidence: 99%
“…In view of the known ability of certain lectins to preferentially bind tumor cells [11], it appeared that lectins could be used as specific targeting agents for porphyrin photosensitizers in PDT. Previous studies reporting the preparation and evaluation of the efficacy of some lectindrug conjugates on tumor cells and animal models support the above idea [12][13][14]. Therefore, we initiated a long-term Correspondence to M. J. Swamy, School of Chemistry, University of Hyderabad, Hyderabad 500 046, India.…”
mentioning
confidence: 90%
“…A number of lectin -drug conjugates have also been prepared and some were successful when tested on cultured cells and animal models [32][33][34]. In view of the considerable affinity of TCSL for Cu(II)-and Zn(II)-porphyrins investigated in this study, it is possible to use the lectin as a vehicle for targeting porphyrin-based drugs to tumour tissues in PDT.…”
mentioning
confidence: 99%